Ipca Laboratories acquires further 20% stake in Bayshore, New Jersey

For consideration of USD 1.2 mn

Ipca Laboratories announced that its wholly owned subsidiary, Ipca Laboratories Inc. USA has acquired another 20% share capital of Bayshore Pharmaceuticals (Bayshore), a New Jersey limited liability company for cash consideration of USD 1.2 million. With this acquisition, Bayshore is now a wholly owned step-down subsidiary of the company.

Powered by Capital Market - Live News